Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10965135rdf:typepubmed:Citationlld:pubmed
pubmed-article:10965135lifeskim:mentionsumls-concept:C0029016lld:lifeskim
pubmed-article:10965135lifeskim:mentionsumls-concept:C0009015lld:lifeskim
pubmed-article:10965135lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:10965135lifeskim:mentionsumls-concept:C1539614lld:lifeskim
pubmed-article:10965135lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:10965135lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:10965135lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:10965135pubmed:issue3-4lld:pubmed
pubmed-article:10965135pubmed:dateCreated2000-9-21lld:pubmed
pubmed-article:10965135pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:abstractTextThe Drm gene, first identified in rat cells in our laboratory, appears to play a significant role in early embryo patterning and limb bud development. We have now isolated mouse Drm (mDrm) cDNA as well as genomic DNA clones and have mapped the Drm gene (Cktsf1b1) to murine chromosome 2. Cktsf1b1 is regulated in a tissue specific fashion and is expressed only in nontransformed mouse cells or primary fibroblasts in culture, but not in established transformed or tumor-derived mouse cell lines. The major transcription start sites map to within 69 bp upstream of the initiating ATG. A promoter was contained in the -214 to +1 bp 5' flanking region, and promoter/reporter constructs showed 10-fold higher activity than control in REF-1 (rat), A31 (mouse) and CHO (hamster) cells. The region contains a TATA sequence and multiple potential transcription factor binding sites. Promoter activity was dose-dependently inhibited by cotransfection with either ras or mos oncogenes, but oncogene inhibition was reversed and the overall activity increased when cells were treated with the MAP kinase kinase (MKK) inhibitor PD98059. An NF-1 and Yi-like site, identified in the minimal promoter region, showed different mobility shift patterns when normal and transformed cell nuclear extracts are compared. Mutation of the NF-1 site reduced Cktsf1b1 promoter activity 25%, while mutation of the Yi-like site destroyed all the activity. Our results indicate that the expression of Cktsf1b1, a gene associated with early development and cell transformation, is sensitive to MKK levels and may be regulated via multiple transcription factor complexes.lld:pubmed
pubmed-article:10965135pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:languageenglld:pubmed
pubmed-article:10965135pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:citationSubsetIMlld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10965135pubmed:statusMEDLINElld:pubmed
pubmed-article:10965135pubmed:issn0301-0171lld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:BlairD GDGlld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:CopelandN GNGlld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:GilbertD JDJlld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:JenkinsN ANAlld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:ZhangQQlld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:TopolL ZLZlld:pubmed
pubmed-article:10965135pubmed:authorpubmed-author:AthanasiouMMlld:pubmed
pubmed-article:10965135pubmed:copyrightInfoCopyright 2000 S. Karger AG, Basel.lld:pubmed
pubmed-article:10965135pubmed:issnTypePrintlld:pubmed
pubmed-article:10965135pubmed:volume89lld:pubmed
pubmed-article:10965135pubmed:ownerNLMlld:pubmed
pubmed-article:10965135pubmed:authorsCompleteYlld:pubmed
pubmed-article:10965135pubmed:pagination242-51lld:pubmed
pubmed-article:10965135pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:meshHeadingpubmed-meshheading:10965135...lld:pubmed
pubmed-article:10965135pubmed:year2000lld:pubmed
pubmed-article:10965135pubmed:articleTitleCloning of the murine Drm gene (Cktsf1b1) and characterization of its oncogene suppressible promoter.lld:pubmed
pubmed-article:10965135pubmed:affiliationBasic Research Laboratory, National Cancer Institute, Frederick, MD, USA.lld:pubmed
pubmed-article:10965135pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10965135pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:11464entrezgene:pubmedpubmed-article:10965135lld:entrezgene
entrez-gene:16492entrezgene:pubmedpubmed-article:10965135lld:entrezgene
entrez-gene:17005entrezgene:pubmedpubmed-article:10965135lld:entrezgene
entrez-gene:21825entrezgene:pubmedpubmed-article:10965135lld:entrezgene
entrez-gene:23892entrezgene:pubmedpubmed-article:10965135lld:entrezgene